1. Home
  2. ADTX vs JAGX Comparison

ADTX vs JAGX Comparison

Compare ADTX & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • JAGX
  • Stock Information
  • Founded
  • ADTX 2017
  • JAGX 2013
  • Country
  • ADTX United States
  • JAGX United States
  • Employees
  • ADTX N/A
  • JAGX N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADTX Health Care
  • JAGX Health Care
  • Exchange
  • ADTX Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • ADTX 3.1M
  • JAGX 3.4M
  • IPO Year
  • ADTX 2020
  • JAGX N/A
  • Fundamental
  • Price
  • ADTX $1.19
  • JAGX $2.14
  • Analyst Decision
  • ADTX
  • JAGX Strong Buy
  • Analyst Count
  • ADTX 0
  • JAGX 1
  • Target Price
  • ADTX N/A
  • JAGX $60.00
  • AVG Volume (30 Days)
  • ADTX 466.9K
  • JAGX 90.3K
  • Earning Date
  • ADTX 08-18-2025
  • JAGX 08-19-2025
  • Dividend Yield
  • ADTX N/A
  • JAGX N/A
  • EPS Growth
  • ADTX N/A
  • JAGX N/A
  • EPS
  • ADTX N/A
  • JAGX N/A
  • Revenue
  • ADTX $55,323.00
  • JAGX $11,552,000.00
  • Revenue This Year
  • ADTX $15,768.94
  • JAGX $22.41
  • Revenue Next Year
  • ADTX N/A
  • JAGX $30.00
  • P/E Ratio
  • ADTX N/A
  • JAGX N/A
  • Revenue Growth
  • ADTX N/A
  • JAGX 13.93
  • 52 Week Low
  • ADTX $0.81
  • JAGX $1.93
  • 52 Week High
  • ADTX $14,800.00
  • JAGX $35.25
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 49.24
  • JAGX 35.79
  • Support Level
  • ADTX $0.81
  • JAGX $1.93
  • Resistance Level
  • ADTX $1.29
  • JAGX $2.33
  • Average True Range (ATR)
  • ADTX 0.11
  • JAGX 0.12
  • MACD
  • ADTX 0.02
  • JAGX 0.06
  • Stochastic Oscillator
  • ADTX 76.00
  • JAGX 41.18

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: